Christopher Missling

Christopher Missling, PhD, holds a PhD in Metallorganic Chemistry from Ludwig-Maximilians-Universität München and an MBA from Northwestern University - Kellogg School of Management. Christopher currently serves as President & CEO of Anavex Life Sciences. Previous roles include Head of Investment Banking at Brimberg & Co., Chief Financial Officer at Curis, Inc., and Head of Financial Planning at Aventis. Additionally, Christopher has experience as an Analyst in M&A and Investment Banking at Deutsche Bank.